1108 studies found for:    "Slow Virus Diseases"
Show Display Options
Rank Status Study
1 Completed Feasibility of Measuring Immune Resp, Activation in Foreskin/Mucosa in HIV-, Uncircumcised High-HIV-risk MSM, Lima Peru
Conditions: HIV Infections;   Acquired Immunodeficiency Syndrome;   Lentivirus Infections;   Retroviridae Infections;   RNA Virus Infections;   Virus Diseases;   Sexually Transmitted Diseases, Viral;   Sexually Transmitted Diseases;   Immunologic Deficiency Syndromes;   Immune System Diseases;   Slow Virus Diseases
Interventions: Procedure: Circumcision;   Procedure: Flexible sigmoidoscopy
2 Recruiting Clinical Trial of Recombinant Adenovirus Type 5 AIDS Vaccine
Condition: Acquired Immunodeficiency Syndrome
Interventions: Biological: Ad5-gag;   Biological: Placebo
3 Completed Efficacy and Safety of Peg-Interferon Alpha-2a Plus Ribavirin in Genotype 1 Chronic Hepatitis C Participants Co-Infected With Human Immunodeficiency Virus
Condition: Hepatitis C, Chronic
Interventions: Drug: Peg-Interferon Alpha-2A;   Drug: Ribavirin
4 Recruiting Using Telmisartan With ART During Acute HIV Infection to Reduce the CNS Reservoirs of HIV and Lymph Node Fibrosis
Conditions: Acute HIV Infection;   HIV CNS Involvement
Interventions: Drug: TDF/3TC/EFV + Telmisartan;   Drug: TDF/3TC/EFV only
5 Not yet recruiting Modulating the Impact of Critical Events in Early HIV Infection: Effect of ART Initiation and Alcohol Use
Condition: HIV Infection
Interventions: Other: ART initiation at time of HIV diagnosis;   Other: ART at 24 weeks post-diagnosis
6 Not yet recruiting Bioequivalence Study of a Fixed-dose Combination (FDC) of Dolutegravir (DTG) and Rilpivirine (RPV)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: DTG;   Drug: RPV;   Drug: DTG/RPV FDC
7 Not yet recruiting Safety and Immunogenicity of a Tetravalent Dengue Vaccine in HIV-Positive Adults
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever;   Human Immunodeficiency Virus
Interventions: Biological: CYD Dengue Vaccine;   Biological: Placebo (NaCl 0.9%) vaccine group
8 Not yet recruiting Relative Bio-availability Study of Dolutegravir and Lamivudine Fixed Dose Combinations
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Dolutegravir 50 mg tablet;   Drug: Lamivudine 300 mg tablet;   Drug: Dolutegravir/Lamivudine 50 mg/300 mg Tablet (Product Code AA);   Drug: Dolutegravir/Lamivudine 50 mg/300 mg Tablet (Product Code AB)
9 Recruiting A Study to Evaluate the Efficacy and Safety of Experimental Drugs ABT- 493/ABT-530 in Adults With Chronic Hepatitis C Virus Genotype 1-6 Infection and Human Immunodeficiency Virus -1 Coinfection (EXPEDITION-2)
Conditions: Hepatitis C Virus Infection;   Human Immunodeficiency Virus Infection;   Chronic Hepatitis C;   Compensated Cirrhosis and Non-cirrhotics
Intervention: Drug: ABT-493/ABT-530
10 Completed Efficacy, and Safety Study of Optimized Background Antiretroviral Regimen (OB) in Combination With Enfuvirtide in the Treatment-Experienced Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection
Condition: HIV Infections
Interventions: Drug: Enfuvirtide;   Drug: Optimized background antiretroviral regimen (OB)
11 Completed MMR Vaccination Among HIV-infected Adults
Condition: HIV
Intervention: Biological: 0.5 ml of MMR vaccine
12 Recruiting Reducing Hazardous Alcohol Use & Human Immunodeficiency Virus (HIV) Viral Load
Conditions: Alcohol Drinking;   HIV
Interventions: Behavioral: Brief Intervention;   Behavioral: Motivational Enhancement Therapy (MET) Intervention;   Behavioral: Cognitive Behavioral Therapy (CBT) Intervention
13 Recruiting A Study to Evaluate the Effects of Multiple Doses of MK-1439 (Doravirine) on Pharmacokinetics of Methadone in Participants Requiring Methadone Maintenance Therapy (MK-1439-045)
Condition: Human Immunodeficiency Virus (HIV) Infection
Interventions: Drug: Maintenance Methadone;   Drug: MK-1439
14 Active, not recruiting Testing for Tuberculosis in the United Kingdom HIV Infected Population
Conditions: HIV;   Latent Tuberculosis
Interventions: Radiation: Chest radiograph;   Procedure: Blood interferon gamma release assay;   Procedure: Tuberculin skin testing (TST);   Procedure: Sputum induction for mycobacterial microscopy and culture;   Other: Mycobacterium tuberculosis polymerase chain reaction testing;   Procedure: Spirometry
15 Not yet recruiting Effectiveness of Nurse-delivered Care for Adherence/Mood in HIV in South Africa
Conditions: Immunodeficiency Virus, Human;   Depressive Symptoms
Intervention: Behavioral: Cognitive Behavioral Therapy for Adherence and Depression
16 Not yet recruiting Addressing Psychosocial Comorbidities in HIV Treatment and Prevention
Conditions: Human Immunodeficiency Virus;   Depression;   Mental Health
Intervention: Behavioral: Cognitive Behavioral Therapy
17 Recruiting Adoptive Cellular Immunotherapy for Progressive Multifocal Leukoencephalopathy With Ex Vivo Generated Polyomavirus-Specific T-Cells
Condition: Leukoencephalopathy
Interventions: Biological: PyVST;   Other: No Intervention
18 Not yet recruiting Cooperative Re-Engagement Controlled Trial (CoRECT)
Condition: Human Immunodeficiency Virus
Intervention: Other: Anti-Retroviral Treatment and Access to Services (ARTAS)
19 Not yet recruiting Efficacy of Intrathecal Administration of Liposomal Amphotericin B in Cryptococcal Meningitis
Condition: Cryptococcal Meningitis
Intervention: Drug: Liposomal amphotericin B
20 Recruiting Safety, Tolerability and Immunogenicity Study of Different Vaccine Schedules With Ad26.Mos.HIV and Clade C Glycoprotein (gp)140 in Healthy Human Immunodeficiency Virus (HIV)-Uninfected Adults
Condition: Healthy
Interventions: Biological: Ad26.Mos.HIV;   Biological: Clade C gp140;   Drug: Placebo

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years